C-Terminal VWF Variants in von Willebrand Disease: Functional Insights from the D4-C6 Domains
The RPTH Journal (Research and Practice in Thrombosis and Haemostasis) shared an insightful post on LinkedIn:
”A small panel of VWF variants were investigated for expression and function – and how they might cause Von Willebrand Disease.
Golzar Mobayen and team reveal that the D4 and C-domains of VWF might play a role!
Other Authors: Sammy El-Mansi, Alain Chion, Tom Nightingale, and Tom McKinnon.”
Read the full article here.
The ”Probing rare von Willebrand disease–causing mutations in the D4 and C-domains of von Willebrand factor” study published by Golzar Mobayen et al. in the RPTH Journal, sheds light on the possible roles of vWF C-terminal D4-C6 domains in development of VWD.
Von Willebrand disease (VWD) arises from quantitative or qualitative deficiencies in von Willebrand factor (VWF), with a broad spectrum of genetic variants contributing to disease pathology.
However, mutations within the C-terminal D4-C6 domains of VWF remain under-characterized.
The findings demonstrate that variants in this region can significantly impair VWF expression and function.
Furthermore, the phenotypic impact varies depending on zygosity, with distinct differences observed between homozygous and heterozygous states.
These insights underscore the importance of the VWF C-terminal domains in maintaining normal hemostatic function.
All the latest scientific advancements on bleeding disorders featured in Hemostasis Today.
-
Jul 26, 2025, 18:32From Jawless Fish to Mammals: Clotting Cascade Origins
-
Jul 26, 2025, 15:12ISTH 2025 Guidelines: Submit Your Topic Proposals by September 8
-
Jul 26, 2025, 15:05Beyond the Needle: The BUTTERFLY Study Eases LMWH Burden
-
Jul 26, 2025, 14:58Join ATHN's Glanzmann Thrombasthenia Research: Help Advance Bleeding Disorder Care
-
Jul 26, 2025, 13:16Dr. William Aird on Diagnosing ITP: Key Clinical Clues
-
Jul 26, 2025, 18:21C-Terminal VWF Variants in von Willebrand Disease: Functional Insights from the D4-C6 Domains
-
Jul 26, 2025, 17:271 Hypothesis, Multiple Implications: Adenoviral Vector Vaccines and Thrombosis with Thrombocytopenia Syndrome
-
Jul 25, 2025, 05:40Why Is Gene Therapy Uptake in Hemophilia Slower Than Expected
-
Jul 25, 2025, 05:27New Insights: Diagnosing Pulmonary Embolism in COPD Patients
-
Jul 25, 2025, 05:11Global Study Sheds Light on Low-Dose Prophylaxis in Hemophilia A
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 13, 2025, 15:35World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
-
Jul 26, 2025, 16:14Cesar Garrido: Forging Strong Partnerships on WHA78 ''Global Health Equity'' Event
-
Jul 23, 2025, 15:34Don't Miss the Hemophilia B Virtual Event on July 29 – Sign Up Now!
-
Jul 23, 2025, 11:05Haemnet Gives Voice to Parents Facing the Challenges of Childhood Bleeding Disorders
-
Jul 23, 2025, 10:43From Blood Clot Survivor to NFL History: Trey Smith’s Record Deal
-
Jul 22, 2025, 16:48How Children See Blood Clots: World Thrombosis Day Shares Artwork from Young Artists